Evidence map›Paper›PMID 33537171›Full record

ArticleOncoimmunology2021

Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring

Wei Nie, Lu Gan, Xin Wang, Kai Gu, Fang-Fei Qian, Min-Juan Hu, Ding Zhang, Shi-Qing Chen, Jun Lu, Shu-Hui Cao and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncoimmunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Observational
  3. Biomarkers for Immunotherapy in Driver-Gene-Negative Advanced NSCLC.International journal of molecular sciences · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Wei NieDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Lu GanDepartment of Oncology, Zhongshan Hospital, Fudan University, Shanghai, China.
Xin WangDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Kai GuInstitute of Pathology, Fudan University, Shanghai, China.
Fang-Fei QianDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Min-Juan HuDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Ding ZhangThe Medical Department, 3D Medicines Inc., Shanghai, China.
Shi-Qing ChenThe Medical Department, 3D Medicines Inc., Shanghai, China.
Jun LuDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Shu-Hui CaoDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Jing-Wen LiDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Yue WangDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Bo ZhangDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Shu-Yuan WangDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Chang-Hui LiDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Ping YangDepartment of Health Sciences Research, Mayo Clinic, Scottsdale, AZ, USA.
Mi-Die XuDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
Xue-Yan ZhangDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Hua ZhongDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
Bao-Hui HanDepartment of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.ORCID 0000-0002-3950-3030

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Somatic mutations of

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsAMP-Activated Protein Kinase KinasesAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedDocetaxelHumansKelch-Like ECH-Associated Protein 1MutationNF-E2-Related Factor 2Protein Serine-Threonine KinasesAMP-Activated Protein Kinase KinasesAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedatezolizumabDocetaxelKEAP1 protein, humanKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Protein Serine-Threonine KinasesSTK11 protein, humanimmune checkpoint inhibitorKEAP1NSCLCSTK11

Identifiers

PMID33537171
PMCPMC7833760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.